Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Poilievre’s Economic Gambit Sends Shockwaves Through Bay Street

Pierre Poilievre isn’t waiting to ease into Canada’s economic debate—he’s kicking the doors wide open with a policy platform that’s shaking up investors, policymakers, and the climate crowd all at once. F...
Lyndsay Malchuk | 9 hours ago |

Carney’s Playbook: 10 Catalysts Set to Shake Up Markets

Canada’s economic roadmap is getting a dramatic rewrite—and investors are already lining up. Prime Minister Mark Carney’s 10-point playbook outlines a sweeping series of catalysts that could spark sector-specific rallies, unlock new capital...
Lyndsay Malchuk | 12 days ago |

How can I invest my TFSA?

A TFSA is a tax-free savings account, offering potential for long-term growth. As of January 1st, 2025 The CRA is increasing the total amount Canadians can contribute to their TSFA by and additional C$7K. You can also use your TFSA to invest in precious...
Coreena Robertson | March 28, 2025 |

Revolutionizing the material world: Tackling the antimicrobial health crisis

With sustainability at the forefront of our minds, one company is leading the path of innovation in developing and manufacturing a diverse range of safe and ecofriendly chemical compounds, Biosenta Inc. Stockhouse Publishing recently caught up with the company&CloseCur...
Lyndsay Malchuk | March 27, 2025 |

Can you get an investing edge using Emotional Intelligence?

Carolyn Stern , a certified Emotional Intelligence and Leadership Development Expert, and an award-winning author of The Emotionally Strong Leader joins The Market Online to discuss Emotional Intelligence in Investing and financial decision-making. Emotional intell...
Coreena Robertson | March 18, 2025 |

AI's Market Disruption: Hype, Reality, and Investment Strategies

In the latest episode of Contributors Corner , hosts Lyndsay Malchuk and Michael Succurro, alongside guest Neel Singh, dove into one of the most transformative forces reshaping industries today: artificial intelligence. As AI continues its relentless expansion, investors...
Lyndsay Malchuk | March 7, 2025 |

Decoding patient data sets to help clinical trials succeed

How well do you know your clinical patients? What if there was a way to uncover the hidden relationship between patients in clinical trials empowering scientists to make critical decisions. Lyndsay Malchuk from Stockhouse Publishing recently sat down with NetraMark Hold...
Lyndsay Malchuk | March 3, 2025 |

Buzz on the Bullboards: High turbulence in a short week

The TSX came out of a holiday long weekend flat but picked up steam by the close. Canada’s main stock index fell on Wednesday as investors let concern over US President Donald Trump’s threat of tariffs on automobiles get the better of the...
Jonathon Brown | February 20, 2025 |

Exosome production crucial for regenerative therapy research and development

NurExone Biologic Inc. (TSXV:NRX) has been making significant strides in the field of exosome-based therapies. And just last month the company announced the acquisition of a US master cell bank, followed by the formation of Exo-Top Inc. Lyndsay Malchuk from Stockho...
Lyndsay Malchuk | February 20, 2025 |

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
Research | January 9, 2025 |
1 2 3 4 5 6 7 8 9 10 ...